HPSE and breast carcinoma: To translate the in vitro inhibition of heparanase enzymatic activity and cell invasion to preclinical models, the most promising triazolo–thiadiazole compounds were examined in the 4T1 mouse mammary carcinoma model of experimental metastasis and the MPC-11 mouse model of myeloma tumor growth [20,32].